- The aim of initial assessment is to establish the prognosis and the need for highly active antiretroviral therapy (HAART).
- Diagnosis and management varies between resource-intensive settings and resource-limited settings.
- Patients should be clinically staged according to WHO or Centers for Disease Control and Prevention (CDC) criteria.
- All patients should have a CD4 count, hepatitis B and C screen, VDRL, tuberculin skin test, and CXR. HIV viral load is also assessed at baseline in most developed countries. Drug resistance testing (genotype/phenotype) is recommended in settings with high levels of circulating resistant virus.
- TB and Pneumocystis jirovecii pneumonia prophylaxis and immunisation with pneumococcal, influenza, hepatitis B and A, and tetanus vaccines should be considered.
- The decision to initiate HAART depends on the patient's clinical stage, CD4 count, medical comorbidities, and ability to adhere to chronic HIV treatment.
Other related conditions
- Overview of HIV
- HIV infection in pregnancy
- HIV-related opportunistic infections
- Assessment of dermatological disorders in HIV
- Assessment of HIV-related mental status changes
- Overview of sexually transmitted diseases
- Pulmonary tuberculosis
- Extrapulmonary tuberculosis
- Pneumocystis jirovecii pneumonia
- Herpes zoster infection
- Oral candidiasis
- Kaposi's sarcoma
Last updated: Jul 02, 2012